A regional quality improvement project to improve the standards of care for people with diabetes who are on maintenance haemodialysis.

People with end-stage renal disease (ESRD) caused by diabetes account for 29.4% of people on maintenance haemodialysis (MHDx). When taking into account those with diabetes not causing ESRD, this figure rises up to 40% in some units.1 People with diabetes and kidney disease are at a particularly high risk of complications such as non-traumatic lower extremity amputation, cardiovascular events and death, with overall survival on MHDx in people with diabetes being approximately half that of their non-diabetic peers (3.7 vs 7.0 years).2–4 In 2016, guidelines were published by the Joint British Diabetes Societies in conjunction with the Renal Association, aimed at …